Parkinson's Disease — Rhythmic Auditory Stimulation Optimalization for Gait Improvement in Parkinson's Disease - BeatPark Study
Citation(s)
Arias P, Cudeiro J Effect of rhythmic auditory stimulation on gait in Parkinsonian patients with and without freezing of gait. PLoS One. 2010 Mar 22;5(3):e9675. doi: 10.1371/journal.pone.0009675.
Arias P, Cudeiro J Effects of rhythmic sensory stimulation (auditory, visual) on gait in Parkinson's disease patients. Exp Brain Res. 2008 Apr;186(4):589-601. doi: 10.1007/s00221-007-1263-y. Epub 2008 Jan 23.
Bloem BR, Hausdorff JM, Visser JE, Giladi N Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov Disord. 2004 Aug;19(8):871-84. Review.
Brown LA, de Bruin N, Doan JB, Suchowersky O, Hu B Novel challenges to gait in Parkinson's disease: the effect of concurrent music in single- and dual-task contexts. Arch Phys Med Rehabil. 2009 Sep;90(9):1578-83. doi: 10.1016/j.apmr.2009.03.009.
del Olmo MF, Cudeiro J Temporal variability of gait in Parkinson disease: effects of a rehabilitation programme based on rhythmic sound cues. Parkinsonism Relat Disord. 2005 Jan;11(1):25-33. Epub 2004 Dec 9.
Delignières D, Torre K Fractal dynamics of human gait: a reassessment of the 1996 data of Hausdorff et al. J Appl Physiol (1985). 2009 Apr;106(4):1272-9. doi: 10.1152/japplphysiol.90757.2008. Epub 2009 Feb 19.
Dujardin K, Sockeel P, Carette AS, Delliaux M, Defebvre L Assessing apathy in everyday clinical practice with the short-form Lille Apathy Rating Scale. Mov Disord. 2013 Dec;28(14):2014-9. doi: 10.1002/mds.25584. Epub 2013 Jul 8.
Elbers RG, van Wegen EE, Verhoef J, Kwakkel G Is gait speed a valid measure to predict community ambulation in patients with Parkinson's disease? J Rehabil Med. 2013 Apr;45(4):370-5. doi: 10.2340/16501977-1123.
Gibb WR, Lees AJ The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52. Review.
Hausdorff JM Gait dynamics in Parkinson's disease: common and distinct behavior among stride length, gait variability, and fractal-like scaling. Chaos. 2009 Jun;19(2):026113. doi: 10.1063/1.3147408. Review.
Hove MJ, Suzuki K, Uchitomi H, Orimo S, Miyake Y Interactive rhythmic auditory stimulation reinstates natural 1/f timing in gait of Parkinson's patients. PLoS One. 2012;7(3):e32600. doi: 10.1371/journal.pone.0032600. Epub 2012 Mar 2.
Howe TE, Lövgreen B, Cody FW, Ashton VJ, Oldham JA Auditory cues can modify the gait of persons with early-stage Parkinson's disease: a method for enhancing parkinsonian walking performance? Clin Rehabil. 2003 Jul;17(4):363-7.
Hughes AJ, Daniel SE, Kilford L, Lees AJ Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4.
Judge JO, Davis RB 3rd, Ounpuu S Step length reductions in advanced age: the role of ankle and hip kinetics. J Gerontol A Biol Sci Med Sci. 1996 Nov;51(6):M303-12.
Kirschner S, Tomasello M Joint drumming: social context facilitates synchronization in preschool children. J Exp Child Psychol. 2009 Mar;102(3):299-314. doi: 10.1016/j.jecp.2008.07.005. Epub 2008 Sep 12.
Lehman DA, Toole T, Lofald D, Hirsch MA Training with verbal instructional cues results in near-term improvement of gait in people with Parkinson disease. J Neurol Phys Ther. 2005 Mar;29(1):2-8.
Marmelat V, Delignières D Strong anticipation: complexity matching in interpersonal coordination. Exp Brain Res. 2012 Oct;222(1-2):137-48. doi: 10.1007/s00221-012-3202-9. Epub 2012 Aug 4.
McIntosh GC, Brown SH, Rice RR, Thaut MH Rhythmic auditory-motor facilitation of gait patterns in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1997 Jan;62(1):22-6.
McIntosh, G C., Rice, R.R., Hurt, C.P., and Thaut, M.H. (1998). Long-term training effects of rhythmic auditory stimulation on gait in patients with Parkinson's disease. Mov. Disord. Off. J. Mov. Disord. Soc. 13 (supple2), 212.
Nieuwboer A Cueing for freezing of gait in patients with Parkinson's disease: a rehabilitation perspective. Mov Disord. 2008;23 Suppl 2:S475-81. doi: 10.1002/mds.21978. Review. Erratum in: Mov Disord. 2008 Aug 15;23(11):1639-40.
Nombela C, Hughes LE, Owen AM, Grahn JA Into the groove: can rhythm influence Parkinson's disease? Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2564-70. doi: 10.1016/j.neubiorev.2013.08.003. Epub 2013 Sep 3. Review.
Repp BH, Su YH Sensorimotor synchronization: a review of recent research (2006-2012). Psychon Bull Rev. 2013 Jun;20(3):403-52. doi: 10.3758/s13423-012-0371-2. Review.
Repp BH Sensorimotor synchronization: a review of the tapping literature. Psychon Bull Rev. 2005 Dec;12(6):969-92. Review.
Rizzolatti G, Fogassi L, Gallese V Neurophysiological mechanisms underlying the understanding and imitation of action. Nat Rev Neurosci. 2001 Sep;2(9):661-70. Review.
Sowinski J, Dalla Bella S Poor synchronization to the beat may result from deficient auditory-motor mapping. Neuropsychologia. 2013 Aug;51(10):1952-63. doi: 10.1016/j.neuropsychologia.2013.06.027. Epub 2013 Jul 6.
Thaut MH, McIntosh KW, McIntosh GC, Hoemberg V Auditory rhythmicity enhances movement and speech motor control in patients with Parkinson's disease. Funct Neurol. 2001 Apr-Jun;16(2):163-72.
Vu TC, Nutt JG, Holford NH Progression of motor and nonmotor features of Parkinson's disease and their response to treatment. Br J Clin Pharmacol. 2012 Aug;74(2):267-83. doi: 10.1111/j.1365-2125.2012.04192.x.
Zatorre RJ, Chen JL, Penhune VB When the brain plays music: auditory-motor interactions in music perception and production. Nat Rev Neurosci. 2007 Jul;8(7):547-58. Review.
Zentner M, Eerola T Rhythmic engagement with music in infancy. Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5768-73. doi: 10.1073/pnas.1000121107. Epub 2010 Mar 15.
Rhythmic Auditory Stimulation Optimalization for Gait Improvement in Parkinson's
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.